Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant FOLFOX4 vs Chemoradiation in Rectal Cancer
NCT05378919Phase 2Recruiting
- Sponsor
- Lithuanian University of Health Sciences
- Start
- Jun 2015
- Primary completion
- Jun 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in rectal cancer, sponsored by Lithuanian University of Health Sciences. Started Jun 2015; status: recruiting.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05378919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378919.